Simaravibart
Product Specifications
Target
SARS-CoV
Related Pathways
Microbiology/Virology
Bioactivity
Simaravibart (MAD-0004J08), an IgG1κ monoclonal antibody, specifically targets the receptor-binding domain of the SARS-CoV-2 spike (S) glycoprotein [1].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1020537-01 0.02 mg (E-Coli)
Recombinant Oryza sativa subsp. japonica 26S protease regulatory subunit 4 homolog (TBP2)
Sign In for Pricing
View Details 
MBS1020537-02 0.02 mg (Yeast)
Recombinant Oryza sativa subsp. japonica 26S protease regulatory subunit 4 homolog (TBP2)
Sign In for Pricing
View Details 
MBS1020537-03 0.1 mg (E-Coli)
Recombinant Oryza sativa subsp. japonica 26S protease regulatory subunit 4 homolog (TBP2)
Sign In for Pricing
View Details MBS1020537-04 0.1 mg (Yeast)
Recombinant Oryza sativa subsp. japonica 26S protease regulatory subunit 4 homolog (TBP2)
Sign In for Pricing
View Details MBS1020537-05 0.02 mg (Baculovirus)
Recombinant Oryza sativa subsp. japonica 26S protease regulatory subunit 4 homolog (TBP2)
Sign In for Pricing
View Details 
MBS1020537-06 0.02 mg (Mammalian-Cell)
Recombinant Oryza sativa subsp. japonica 26S protease regulatory subunit 4 homolog (TBP2)
Sign In for Pricing
View Details